Results 191 to 200 of about 3,357,118 (349)

Gaza: Between global silence and the double standards of justice. [PDF]

Dialogues Health
Asmar I.
europepmc   +1 more source

A Theory of Charitable Fund-Raising with Costly Solicitations [PDF]

Alvaro Name Correa, Huseyin Yildirim
core  

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Accidental puncture of the aorta during subclavian central venous catheterization: a case report. [PDF]

World J Emerg Med
Qin L, Shan H.
europepmc   +1 more source

Online Fund-Raising Mechanisms: A Field Experiment

, 2005
Yan Chen, Xin Li, Jeffrey K. MacKie-Mason   +2 more
semanticscholar   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Key factors associated with China's basic medical insurance fund revenue-expenditure balance: a grey relational analysis. [PDF]

Cost Eff Resour Alloc
Gong G, Dan W, Wei H, Xiping L.
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

The YFM 2012 – Emerging Research and Established Needs: Fund Raising, Publishing and Career Advancement

CHIMIA, 2012
Barbara Winter-Werner, Franziska Schoenebeck, Ryan B Gilmour   +2 more
doaj   +1 more source

Lack of accountability, not budget cuts, is the real humanitarian crisis. [PDF]

Disasters
Mohamud MH.
europepmc   +1 more source